Funds holding PROCESSA PHARMACEUTICALS INC
ISIN US74275C4033 · United States · LEI 529900A51HZIE4XJB960
- Fund holders
- 4
- Of which ETFs
- 0 4 other funds
- Value held
- 68.7K $
- Share of capital
- 1.1 % of 2.8M shares on Aug 7, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 14,221 | 36.4K $ | 0.00 % | 0.51 % | as of May 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 12,729 | 24.4K $ | 0.46 % | as of Jun 30, 2026 ↗ | |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 2,088 | 5.3K $ | 0.07 % | as of May 31, 2026 ↗ | |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 969 | 2.5K $ | 0.03 % | as of May 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of May 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 4 | 0 | 30,007 | -1.5 % |
| 2026Q2 | 4 | +3 | 30,451 | +139.2 % |
| 2026Q1 | 1 | 12,729 |
Institutional managers
8 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| Connective Capital Management, LLC | 70,736 | 178.6K $ | as of Mar 31, 2026 |
| Stonepine Capital Management, LLC | 55,000 | 138.9K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 24,908 | 62.8K $ | as of Mar 31, 2026 |
| UBS Group AG | 2,531 | 6.4K $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 918 | 2.3K $ | as of Mar 31, 2026 |
| CITIGROUP INC | 14 | 35 $ | as of Mar 31, 2026 |
| JONES FINANCIAL COMPANIES LLLP | 7 | 17 $ | as of Mar 31, 2026 |
| WELLS FARGO & COMPANY/MN | 6 | 15 $ | as of Mar 31, 2026 |
Declared shareholders of PROCESSA PHARMACEUTICALS INC
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Soleus Capital Master Fund, L.P. and 5 others | 5.80 % | 160,943 | as of Aug 3, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding PROCESSA PHARMACEUTICALS INC". https://titelia.com/en/stocks/processa-pharmaceuticals-inc-US74275C4033